Erratum: The Akt-SRPK-SR Axis Constitutes a Major Pathway in Transducing EGF Signaling to Regulate Alternative Splicing in the Nucleus (The Akt-SRPK-SR Axis Constitutes a Major Pathway in Transducing EGF Signaling to Regulate Alternative Splicing in the Nucleus (2012) 47(3) (422–433), (S109727651200398X) (10.1016/j.molcel.2012.05.014));The Akt-SRPK-SR Axis Constitutes a Major Pathway in Transducing EGF Signaling to Regulate Alternative Splicing in the Nucleus

Molecular Cell

Volumn 47, Issue 3, 2012, Pages 422-433

  Zhou, Zhihong ^a   Qiu, Jinsong ^a   Liu, Wen ^b   Zhou, Yu ^a   Plocinik, Ryan M ^c   Li, Hairi ^a   Hu, Qidong ^b   Ghosh, Gourisanker ^d   Adams, Joseph A ^c   Rosenfeld, Michael G ^b   Fu, Xiang Dong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c San Diego   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHOTRANSFERASE; PROTEIN KINASE B; SERINE ARGININE RICH PROTEIN; SERINE ARGININE RICH PROTEIN SPECIFIC KINASE 1; SERINE ARGININE RICH PROTEIN SPECIFIC KINASE 2; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; COMPLEX FORMATION; CONTROLLED STUDY; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RNA SPLICING; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 84864910082     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2018.08.024     Document Type: Erratum

References (53)

1. Amin E.M., Oltean S., Hua J., Gammons M.V., Hamdollah-Zadeh M., Welsh G.I., Cheung M.K., Ni L., Kase S., Rennel E.S., et al. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell 2011, 20:768-780.
2. Aubol B.E., Chakrabarti S., Ngo J., Shaffer J., Nolen B., Fu X.D., Ghosh G., Adams J.A. Processive phosphorylation of alternative splicing factor/splicing factor 2. Proc. Natl. Acad. Sci. USA 2003, 100:12601-12606.
3. Blaustein M., Pelisch F., Tanos T., Muñoz M.J., Wengier D., Quadrana L., Sanford J.R., Muschietti J.P., Kornblihtt A.R., Cáceres J.F., et al. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat. Struct. Mol. Biol. 2005, 12:1037-1044.
4. Carracedo A., Pandolfi P.P. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 2008, 27:5527-5541.
5. Cho S., Hoang A., Sinha R., Zhong X.Y., Fu X.-D., Krainer A.R., Ghosh G. Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly. Proc. Natl. Acad. Sci. USA 2011, 108:8233-8238.
6. Concover W.J. Practical nonparametric statistics 1971, John Wiley & Sons, New York, 309-314.
7. Cooper T.A., Wan L., Dreyfuss G. RNA and disease. Cell 2009, 136:777-793.
8. Ding J.H., Zhong X.Y., Hagopian J.C., Cruz M.M., Ghosh G., Feramisco J., Adams J.A., Fu X.D. Regulated cellular partitioning of SR protein-specific kinases in mammalian cells. Mol. Biol. Cell 2006, 17:876-885.
9. Du H., Cline M.S., Osborne R.J., Tuttle D.L., Clark T.A., Donohue J.P., Hall M.P., Shiue L., Swanson M.S., Thornton C.A., Ares M. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol. 2010, 17:187-193.
10. Hayes G.M., Carrigan P.E., Beck A.M., Miller L.J. Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma. Cancer Res. 2006, 66:3819-3827.
11. Hayes G.M., Carrigan P.E., Miller L.J. Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas. Cancer Res. 2007, 67:2072-2080.
12. Hegele A., Kamburov A., Grossmann A., Sourlis C., Wowro S., Weimann M., Will C.L., Pena V., Lührmann R., Stelzl U. Dynamic protein-protein interaction wiring of the human spliceosome. Mol. Cell 2012, 45:567-580.
13. Hernández F., Pérez M., Lucas J.J., Mata A.M., Bhat R., Avila J. Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease. J. Biol. Chem. 2004, 279:3801-3806.
14. Heyd F., Lynch K.W. Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing. Mol. Cell 2010, 40:126-137.
15. Heyd F., Lynch K.W. Degrade, move, regroup: signaling control of splicing proteins. Trends Biochem. Sci. 2011, 36:397-404.
16. Hirai H., Sootome H., Nakatsuru Y., Miyama K., Taguchi S., Tsujioka K., Ueno Y., Hatch H., Majumder P.K., Pan B.S., Kotani H. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol. Cancer Ther. 2010, 9:1956-1967.
17. Hishizawa M., Imada K., Sakai T., Ueda M., Hori T., Uchiyama T. Serological identification of adult T-cell leukaemia-associated antigens. Br. J. Haematol. 2005, 130:382-390.
18. Inoki K., Corradetti M.N., Guan K.L. Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet. 2005, 37:19-24.
19. Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K. Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons. J. Biol. Chem. 2009, 284:24512-24525.
20. Jiang K., Patel N.A., Watson J.E., Apostolatos H., Kleiman E., Hanson O., Hagiwara M., Cooper D.R. Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid. Endocrinology 2009, 150:2087-2097.
21. Jorissen R.N., Walker F., Pouliot N., Garrett T.P.J., Ward C.W., Burgess A.W. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 2003, 284:31-53.
22. King F.W., Wawrzynow A., Höhfeld J., Zylicz M. Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. EMBO J. 2001, 20:6297-6305.
23. König H., Ponta H., Herrlich P. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J. 1998, 17:2904-2913.
24. Krishnakumar S., Mohan A., Kandalam M., Ramkumar H.L., Venkatesan N., Das R.R. SRPK1: a cisplatin sensitive protein expressed in retinoblastoma. Pediatr. Blood Cancer 2008, 50:402-406.
25. Li H., Qiu J., Fu X.-D. RASL-seq for massive parallel and quantitative analysis of gene expression. Curr. Protocol. Mol. Biol. 2012, 98:4.13.1-4.13.9.
26. Lin S., Fu X.D. SR proteins and related factors in alternative splicing. Adv. Exp. Med. Biol. 2007, 623:107-122.
27. Liu X., Mayeda A., Tao M., Zheng Z.M. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway. J. Virol. 2003, 77:2105-2115.
28. Lu Y., Muller M., Smith D., Dutta B., Komurov K., Iadevaia S., Ruths D., Tseng J.-T., Yu S., Yu Q., et al. Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling. Oncogene 2011, 30:4567-4577.
29. Lynch K.W. Regulation of alternative splicing by signal transduction pathways. Adv. Exp. Med. Biol. 2007, 623:161-174.
30. Lynch K.W., Weiss A. A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras. Mol. Cell. Biol. 2000, 20:70-80.
31. Maniatis T., Reed R. An extensive network of coupling among gene expression machines. Nature 2002, 416:499-506.
32. Mathew R., Hartmuth K., Möhlmann S., Urlaub H., Ficner R., Lührmann R. Phosphorylation of human PRP28 by SRPK2 is required for integration of the U4/U6-U5 tri-snRNP into the spliceosome. Nat. Struct. Mol. Biol. 2008, 15:435-443.
33. McCormack A.L., Schieltz D.M., Goode B., Yang S., Barnes G., Drubin D., Yates J.R. Direct analysis and identification of proteins in mixtures by LC/MS/MS and database searching at the low-femtomole level. Anal. Chem. 1997, 69:767-776.
34. Moore M.J., Proudfoot N.J. Pre-mRNA processing reaches back to transcription and ahead to translation. Cell 2009, 136:688-700.
35. Ngo J.C., Chakrabarti S., Ding J.H., Velazquez-Dones A., Nolen B., Aubol B.E., Adams J.A., Fu X.D., Ghosh G. Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2. Mol. Cell 2005, 20:77-89.
36. Nilsen T.W., Graveley B.R. Expansion of the eukaryotic proteome by alternative splicing. Nature 2010, 463:457-463.
37. Nolen B., Yun C.Y., Wong C.F., McCammon J.A., Fu X.D., Ghosh G. The structure of Sky1p reveals a novel mechanism for constitutive activity. Nat. Struct. Biol. 2001, 8:176-183.
38. Pandit S., Wang D., Fu X.D. Functional integration of transcriptional and RNA processing machineries. Curr. Opin. Cell Biol. 2008, 20:260-265.
39. Plasencia C., Martínez-Balibrea E., Martinez-Cardús A., Quinn D.I., Abad A., Neamati N. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells. Int. J. Oncol. 2006, 29:225-235.
40. Schenk P.W., Stoop H., Bokemeyer C., Mayer F., Stoter G., Oosterhuis J.W., Wiemer E., Looijenga L.H., Nooter K. Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1. Neoplasia 2004, 6:297-301.
41. Shi Y., Manley J.L. A complex signaling pathway regulates SRp38 phosphorylation and pre-mRNA splicing in response to heat shock. Mol. Cell 2007, 28:79-90.
42. Shin C., Manley J.L. Cell signalling and the control of pre-mRNA splicing. Nat. Rev. Mol. Cell Biol. 2004, 5:727-738.
43. Shultz J.C., Goehe R.W., Wijesinghe D.S., Murudkar C., Hawkins A.J., Shay J.W., Minna J.D., Chalfant C.E. Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a. Cancer Res. 2010, 70:9185-9196.
44. Siebel C.W., Feng L., Guthrie C., Fu X.D. Conservation in budding yeast of a kinase specific for SR splicing factors. Proc. Natl. Acad. Sci. USA 1999, 96:5440-5445.
45. Song J., Takeda M., Morimoto R.I. Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth. Nat. Cell Biol. 2001, 3:276-282.
46. Velazquez-Dones A., Hagopian J.C., Ma C.T., Zhong X.Y., Zhou H., Ghosh G., Fu X.D., Adams J.A. Mass spectrometric and kinetic analysis of ASF/SF2 phosphorylation by SRPK1 and Clk/Sty. J. Biol. Chem. 2005, 280:41761-41768.
47. Wang H.Y., Lin W., Dyck J.A., Yeakley J.M., Songyang Z., Cantley L.C., Fu X.D. SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. J. Cell Biol. 1998, 140:737-750.
48. Weg-Remers S., Ponta H., Herrlich P., König H. Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J. 2001, 20:4194-4203.
49. Yang X., Bani M.R., Lu S.J., Rowan S., Ben-David Y., Chabot B. The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo. Proc. Natl. Acad. Sci. USA 1994, 91:6924-6928.
50. Yeakley J.M., Fan J.B., Doucet D., Luo L., Wickham E., Ye Z., Chee M.S., Fu X.D. Profiling alternative splicing on fiber-optic arrays. Nat. Biotechnol. 2002, 20:353-358.
51. Zhang X., Clark A.F., Yorio T. Heat shock protein 90 is an essential molecular chaperone for nuclear transport of glucocorticoid receptor β. Invest. Ophthalmol. Vis. Sci. 2006, 47:700-708.
52. Zhong X.Y., Ding J.H., Adams J.A., Ghosh G., Fu X.D. Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev. 2009, 23:482-495.
53. Zylicz M., King F.W., Wawrzynow A. Hsp70 interactions with the p53 tumour suppressor protein. EMBO J. 2001, 20:4634-4638.